{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T16:04:06Z","timestamp":1781712246845,"version":"3.54.5"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,3,14]],"date-time":"2022-03-14T00:00:00Z","timestamp":1647216000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002794","name":"Cancerfonden","doi-asserted-by":"publisher","award":["20 0798 Fk"],"award-info":[{"award-number":["20 0798 Fk"]}],"id":[{"id":"10.13039\/501100002794","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001725","name":"Kungliga Vetenskapsakademien","doi-asserted-by":"publisher","award":["ME2019\\u20130036"],"award-info":[{"award-number":["ME2019\\u20130036"]}],"id":[{"id":"10.13039\/501100001725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010817","name":"Stiftelsen Kronprinsessan Margaretas Arbetsn\u00e4mnd F\u00f6r Synskadade","doi-asserted-by":"publisher","award":["157"],"award-info":[{"award-number":["157"]}],"id":[{"id":"10.13039\/100010817","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010810","name":"\u00d6gonfonden","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010810","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007687","name":"Svenska L\u00e4kares\u00e4llskapet","doi-asserted-by":"publisher","award":["SLS 934014"],"award-info":[{"award-number":["SLS 934014"]}],"id":[{"id":"10.13039\/501100007687","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004348","name":"Region Stockholm","doi-asserted-by":"publisher","award":["20200356"],"award-info":[{"award-number":["20200356"]}],"id":[{"id":"10.13039\/501100004348","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018666","name":"Carmen and Bertil Regn\u00e9r Foundation for Eye Disease Research","doi-asserted-by":"publisher","award":["2020\\u201300062"],"award-info":[{"award-number":["2020\\u201300062"]}],"id":[{"id":"10.13039\/100018666","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Critical Reviews in Oncology\/Hematology"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1016\/j.critrevonc.2022.103652","type":"journal-article","created":{"date-parts":[[2022,3,15]],"date-time":"2022-03-15T13:28:39Z","timestamp":1647350919000},"page":"103652","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"special_numbering":"C","title":["The long-term prognosis of patients with untreated primary uveal melanoma: A systematic review and meta-analysis"],"prefix":"10.1016","volume":"172","author":[{"given":"Gustav","family":"St\u00e5lhammar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viktor T.","family":"Gill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.critrevonc.2022.103652_bib1","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1016\/S0161-6420(84)34088-X","article-title":"Growth rates and doubling times of posterior uveal melanomas","volume":"91","author":"Augsburger","year":"1984","journal-title":"Ophthalmology"},{"issue":"10","key":"10.1016\/j.critrevonc.2022.103652_bib2","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1001\/archopht.1993.01090100090033","article-title":"Impact of delayed treatment in growing posterior uveal melanomas","volume":"111","author":"Augsburger","year":"1993","journal-title":"Arch. Ophthalmol."},{"issue":"5","key":"10.1016\/j.critrevonc.2022.103652_bib3","first-page":"675","article-title":"[Natural history of malignant melanoma of the uvea (apropos of 2 cases: 1--Malignant melanoma of the uvea followed-up without treatment during 25 years. 2--Simultaneous discovery of a malignant melanoma of the uvea and meningeal metastases)]","volume":"88","author":"Bacin","year":"1988","journal-title":"Bull. Soc. Ophtalmol. Fr."},{"issue":"8","key":"10.1016\/j.critrevonc.2022.103652_bib4","doi-asserted-by":"crossref","first-page":"3282","DOI":"10.1167\/iovs.03-0081","article-title":"Uveal melanoma survival in Sweden from 1960 to 1998","volume":"44","author":"Bergman","year":"2003","journal-title":"Investig. Ophthalmol. Visual Sci."},{"issue":"5","key":"10.1016\/j.critrevonc.2022.103652_bib5","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1159\/000515559","article-title":"Uveal melanoma: refusal of treatment","volume":"7","author":"Bowen","year":"2021","journal-title":"Ocul. Oncol. Pathol."},{"issue":"4","key":"10.1016\/j.critrevonc.2022.103652_bib6","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1016\/S0161-6420(94)31274-7","article-title":"Natural history of indeterminate pigmented choroidal tumors","volume":"101","author":"Butler","year":"1994","journal-title":"Ophthalmology"},{"issue":"7","key":"10.1016\/j.critrevonc.2022.103652_bib7","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1001\/archophthalmol.2011.181","article-title":"Sudden growth of a choroidal melanoma and multiplex ligation-dependent probe amplification findings suggesting late transformation to monosomy 3 type","volume":"129","author":"Callejo","year":"2011","journal-title":"Arch. Ophthalmol."},{"issue":"8","key":"10.1016\/j.critrevonc.2022.103652_bib8","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1001\/archopht.1997.01100160184007","article-title":"Uveal melanoma. Growth rate and prognosis","volume":"115","author":"Char","year":"1997","journal-title":"Arch. Ophthalmol."},{"issue":"12","key":"10.1016\/j.critrevonc.2022.103652_bib9","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1001\/archopht.124.12.1684","article-title":"The COMS randomized trial of iodine 125 brachytherapy for choroidal melanoma: V. Twelve-year mortality rates and prognostic factors: COMS Report No. 28","volume":"124","author":"COMS","year":"2006","journal-title":"Arch. Ophthalmol."},{"issue":"8","key":"10.1016\/j.critrevonc.2022.103652_bib10","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1097\/ACM.0000000000000786","article-title":"Appraising the quality of medical education research methods: the medical education research study quality instrument and the Newcastle-Ottawa Scale-Education","volume":"90","author":"Cook","year":"2015","journal-title":"Acad. Med."},{"issue":"3","key":"10.1016\/j.critrevonc.2022.103652_bib11","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1038\/sj.bjc.6605765","article-title":"Does ocular treatment of uveal melanoma influence survival?","volume":"103","author":"Damato","year":"2010","journal-title":"Brit. J. Cancer"},{"key":"10.1016\/j.critrevonc.2022.103652_bib12","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.preteyeres.2018.03.004","article-title":"Ocular treatment of choroidal melanoma in relation to the prevention of metastatic death - a personal view","volume":"66","author":"Damato","year":"2018","journal-title":"Prog. Retin. Eye Res."},{"issue":"2","key":"10.1016\/j.critrevonc.2022.103652_bib13","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s12032-018-1230-4","article-title":"Risk factors, clinical outcomes, and natural history of uveal melanoma: a single-institution analysis","volume":"36","author":"Delgado-Ramos","year":"2019","journal-title":"Med. Oncol."},{"issue":"8","key":"10.1016\/j.critrevonc.2022.103652_bib14","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1016\/S0161-6420(00)00182-2","article-title":"Tumor doubling times in metastatic malignant melanoma of the uvea: tumor progression before and after treatment","volume":"107","author":"Eskelin","year":"2000","journal-title":"Ophthalmology"},{"issue":"1","key":"10.1016\/j.critrevonc.2022.103652_bib15","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1038\/s41467-017-02428-w","article-title":"Punctuated evolution of canonical genomic aberrations in uveal melanoma","volume":"9","author":"Field","year":"2018","journal-title":"Nat. Commun."},{"issue":"6","key":"10.1016\/j.critrevonc.2022.103652_bib16","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/S0161-6420(80)35200-7","article-title":"Observation of suspected choroidal and ciliary body melanomas for evidence of growth prior to enucleation","volume":"87","author":"Gass","year":"1980","journal-title":"Ophthalmology"},{"issue":"11","key":"10.1016\/j.critrevonc.2022.103652_bib17","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1001\/archopht.1978.03910060469017","article-title":"Choroidal melanocytic tumor observed for 41 years before enucleation","volume":"96","author":"Gundersen","year":"1978","journal-title":"Arch. Ophthalmol."},{"issue":"6009","key":"10.1016\/j.critrevonc.2022.103652_bib18","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1126\/science.1194472","article-title":"Frequent mutation of BAP1 in metastasizing uveal melanomas","volume":"330","author":"Harbour","year":"2010","journal-title":"Science"},{"issue":"6","key":"10.1016\/j.critrevonc.2022.103652_bib19","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1016\/j.ajo.2004.07.006","article-title":"The Collaborative Ocular Melanoma Study (COMS) randomized trial of pre-enucleation radiation of large choroidal melanoma: IV. Ten-year mortality findings and prognostic factors. COMS report number 24","volume":"138","author":"Hawkins","year":"2004","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.critrevonc.2022.103652_bib20","unstructured":"Higgins, J.P.T., Cochrane Collaboration, 2020. Cochrane handbook for systematic reviews of interventions, Second edition. ed. Wiley-Blackwell, Hoboken, NJ."},{"key":"10.1016\/j.critrevonc.2022.103652_bib21","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.ajo.2019.01.031","article-title":"The small fatal choroidal melanoma study. A survey by the European ophthalmic oncology group","volume":"202","author":"Jouhi","year":"2019","journal-title":"Am. J. Ophthalmol."},{"issue":"2","key":"10.1016\/j.critrevonc.2022.103652_bib22","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1001\/jamaophthalmol.2015.5233","article-title":"Long-term risk of melanoma-related mortality after uveal melanoma","volume":"134","author":"Kivela","year":"2016","journal-title":"JAMA Ophthalmol."},{"issue":"2","key":"10.1016\/j.critrevonc.2022.103652_bib23","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1111\/aos.13535","article-title":"The first description of the complete natural history of uveal melanoma by two Scottish surgeons, Allan Burns and James Wardrop","volume":"96","author":"Kivela","year":"2018","journal-title":"Acta Ophthalmol."},{"issue":"11","key":"10.1016\/j.critrevonc.2022.103652_bib24","doi-asserted-by":"crossref","first-page":"4651","DOI":"10.1167\/iovs.03-0538","article-title":"Very long-term prognosis of patients with malignant uveal melanoma","volume":"44","author":"Kujala","year":"2003","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"issue":"2","key":"10.1016\/j.critrevonc.2022.103652_bib25","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/PL00007880","article-title":"Long-term follow-up of Ru-106\/Rh-106 brachytherapy for posterior uveal melanoma","volume":"238","author":"Lommatzsch","year":"2000","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"issue":"1","key":"10.1016\/j.critrevonc.2022.103652_bib26","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/BF00161154","article-title":"The natural history of uveal melanomas and its therapeutic consequences","volume":"50","author":"Manschot","year":"1980","journal-title":"Doc. Ophthalmol."},{"issue":"8","key":"10.1016\/j.critrevonc.2022.103652_bib27","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1016\/j.ophtha.2012.02.017","article-title":"Collaborative ocular oncology group report number 1: prospective validation of a multi-gene prognostic assay in uveal melanoma","volume":"119","author":"Onken","year":"2012","journal-title":"Ophthalmology"},{"issue":"11","key":"10.1016\/j.critrevonc.2022.103652_bib28","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1001\/archopht.1986.01050230062032","article-title":"Metastasis from untreated uveal melanomas","volume":"104","author":"Pach","year":"1986","journal-title":"Arch. Ophthalmol."},{"issue":"5","key":"10.1016\/j.critrevonc.2022.103652_bib29","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0250939","article-title":"Uveal melanoma: long-term survival","volume":"16","author":"Radivoyevitch","year":"2021","journal-title":"PLoS One"},{"issue":"S133","key":"10.1016\/j.critrevonc.2022.103652_bib30","first-page":"1","article-title":"Uveal melanoma in Finland; an epidemiological, clinical, histological and prognostic study","volume":"55","author":"Raivio","year":"1977","journal-title":"Acta Ophthalmol. Scand."},{"issue":"1","key":"10.1016\/j.critrevonc.2022.103652_bib31","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1007\/s00066-006-1454-7","article-title":"Neoadjuvant interstitial high-dose-rate (HDR) brachytherapy combined with systemic chemotherapy in patients with breast cancer","volume":"182","author":"Roddiger","year":"2006","journal-title":"Strahlenther. Onkol."},{"key":"10.1016\/j.critrevonc.2022.103652_bib32","article-title":"Vasculogenic mimicry correlates to presenting symptoms and mortality in uveal melanoma","author":"Sabazade","year":"2021","journal-title":"J. Cancer Res. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.critrevonc.2022.103652_bib33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12885-021-09002-0","article-title":"No differences in the long-term prognosis of iris and choroidal melanomas when adjusting for tumor thickness and diameter","volume":"21","author":"Sabazade","year":"2021","journal-title":"BMC Cancer"},{"issue":"2","key":"10.1016\/j.critrevonc.2022.103652_bib34","first-page":"169","article-title":"Natural history of malignant melanoma of the choroid","volume":"11","author":"Saraux","year":"1988","journal-title":"J. Fr. Ophtalmol."},{"issue":"8","key":"10.1016\/j.critrevonc.2022.103652_bib35","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1001\/archophthalmol.2009.208","article-title":"Metastasis of uveal melanoma millimeter-by-millimeter in 8033 consecutive eyes","volume":"127","author":"Shields","year":"2009","journal-title":"Arch. Ophthalmol."},{"issue":"7","key":"10.1016\/j.critrevonc.2022.103652_bib36","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1097\/IAE.0b013e31824d09a8","article-title":"Clinical spectrum and prognosis of uveal melanoma based on age at presentation in 8,033 cases","volume":"32","author":"Shields","year":"2012","journal-title":"Retina"},{"issue":"5","key":"10.1016\/j.critrevonc.2022.103652_bib37","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/S0161-6420(00)00607-2","article-title":"Uveal melanoma: implications of tumor doubling time","volume":"108","author":"Singh","year":"2001","journal-title":"Ophthalmology"},{"issue":"9","key":"10.1016\/j.critrevonc.2022.103652_bib38","doi-asserted-by":"crossref","first-page":"3335","DOI":"10.1167\/iovs.16-20465","article-title":"Comparison of alternative tumor size classifications for posterior uveal melanomas","volume":"58","author":"Skinner","year":"2017","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"issue":"1","key":"10.1016\/j.critrevonc.2022.103652_bib39","doi-asserted-by":"crossref","first-page":"11297","DOI":"10.1038\/s41598-020-68232-7","article-title":"Forty-year prognosis after plaque brachytherapy of uveal melanoma","volume":"10","author":"Stalhammar","year":"2020","journal-title":"Sci. Rep."},{"issue":"3","key":"10.1016\/j.critrevonc.2022.103652_bib40","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1055\/s-2008-1054751","article-title":"Verlauf eines \u00fcber 30 Jahre beobachteten Aderhautmelanoms","volume":"182","author":"Stefani","year":"1983","journal-title":"Klin Monbl. Augenheilkd."},{"issue":"1","key":"10.1016\/j.critrevonc.2022.103652_bib41","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0002-9394(02)02270-5","article-title":"Mortality after deferral of treatment or no treatment for choroidal melanoma","volume":"136","author":"Straatsma","year":"2003","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.critrevonc.2022.103652_bib42","first-page":"502","article-title":"Density of PAS positive patterns in uveal melanoma: correlation with vasculogenic mimicry, gene expression class, BAP-1 expression, macrophage infiltration, and risk for metastasis","volume":"25","author":"St\u00e5lhammar","year":"2019","journal-title":"Mol. Vision"},{"issue":"1","key":"10.1016\/j.critrevonc.2022.103652_bib43","doi-asserted-by":"crossref","first-page":"8923","DOI":"10.1038\/s41598-021-88390-6","article-title":"Estimation of the timing of BAP1 mutation in uveal melanoma progression","volume":"11","author":"Uner","year":"2021","journal-title":"Sci. Rep."},{"issue":"10","key":"10.1016\/j.critrevonc.2022.103652_bib44","doi-asserted-by":"crossref","first-page":"4096","DOI":"10.1167\/iovs.17-22255","article-title":"PRiMeUM: a model for predicting risk of metastasis in uveal melanoma","volume":"58","author":"Vaquero-Garcia","year":"2017","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"issue":"1","key":"10.1016\/j.critrevonc.2022.103652_bib45","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1093\/ndt\/gfq661","article-title":"The analysis of competing events like cause-specific mortality--beware of the Kaplan-Meier method","volume":"26","author":"Verduijn","year":"2011","journal-title":"Nephrol. Dial Transplant"},{"issue":"10","key":"10.1016\/j.critrevonc.2022.103652_bib46","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1001\/archopht.126.10.1413","article-title":"Survival in patients with uveal melanoma in Europe","volume":"126","author":"Virgili","year":"2008","journal-title":"Arch. Ophthalmol."},{"issue":"6","key":"10.1016\/j.critrevonc.2022.103652_bib47","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1001\/archopht.1982.01030030947009","article-title":"The incidence of metastases from untreated ciliary body and choroidal melanoma","volume":"100","author":"Wagoner","year":"1982","journal-title":"Arch. Ophthalmol."},{"issue":"3 Pt 1","key":"10.1016\/j.critrevonc.2022.103652_bib48","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/0002-9394(79)90658-5","article-title":"Metastatic disease from untreated uveal melanomas","volume":"88","author":"Zimmerman","year":"1979","journal-title":"Am. J. Ophthalmol."},{"issue":"6","key":"10.1016\/j.critrevonc.2022.103652_bib49","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1136\/bjo.62.6.420","article-title":"Does enucleation of the eye containing a malignant melanoma prevent or accelerate the dissemination of tumour cells","volume":"62","author":"Zimmerman","year":"1978","journal-title":"Brit. J. Ophthalmol."}],"container-title":["Critical Reviews in Oncology\/Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842822000762?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842822000762?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T21:37:00Z","timestamp":1778794620000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1040842822000762"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4]]},"references-count":49,"alternative-id":["S1040842822000762"],"URL":"https:\/\/doi.org\/10.1016\/j.critrevonc.2022.103652","relation":{},"ISSN":["1040-8428"],"issn-type":[{"value":"1040-8428","type":"print"}],"subject":[],"published":{"date-parts":[[2022,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The long-term prognosis of patients with untreated primary uveal melanoma: A systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Critical Reviews in Oncology\/Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.critrevonc.2022.103652","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"103652"}}